Community Group-Based Models of Medication Delivery: Applicability to Cardiovascular Diseases.

Kwon, C; Webster, R; Santo, K; Atkins, E

Community Group-Based Models of Medication Delivery: Applicability to Cardiovascular Diseases.

Kwon, C Webster, R

Santo, K Atkins, E

Permalink

Publisher:: UBIQUITY PRESS LTD
Publication Type:: Journal Article
Citation:: Global heart, 2021, 16, (1), pp. 36
Issue Date:: 2021-05-05

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download Published versionAdobe PDF (1.04 MB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Kwon, C
dc.contributor.author	Webster, R https://orcid.org/0000-0002-7444-3037
dc.contributor.author	Santo, K
dc.contributor.author	Atkins, E
dc.date.accessioned	2021-12-12T08:03:25Z
dc.date.available	2021-12-12T08:03:25Z
dc.date.issued	2021-05-05
dc.identifier.citation	Global heart, 2021, 16, (1), pp. 36
dc.identifier.issn	2211-8160
dc.identifier.issn	2211-8179
dc.identifier.uri	http://hdl.handle.net/10453/152245
dc.description.abstract	The rising global burden of chronic non-communicable diseases (NCDs) has put a strain on healthcare systems globally, especially in low- and middle-income countries, which have seen disproportionate mortality rates due to non-communicable diseases. These deaths are in part due to challenges with medication adherence, which are compounded by lack of access to medication and weak community support systems. This paper aims to propose a potential solution using models of service delivery in HIV/AIDS, given the many similarities between NCD and HIV/AIDS. Models that have been particularly effective in HIV/AIDS are the community-based peer-support medication delivery groups: medication adherence clubs and community antiretroviral therapy (ART) groups. The positive outcomes from these models, including improved medication adherence and patient satisfaction, provide evidence for their potential success when applied to non-communicable diseases, particularly hypertension and cardiovascular disease.
dc.format	Electronic
dc.language	eng
dc.publisher	UBIQUITY PRESS LTD
dc.relation.ispartof	Global heart
dc.relation.isbasedon	10.5334/gh.763
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	1102 Cardiorespiratory Medicine and Haematology
dc.subject.mesh	Humans
dc.subject.mesh	HIV Infections
dc.subject.mesh	Cardiovascular Diseases
dc.subject.mesh	Medication Adherence
dc.subject.mesh	Noncommunicable Diseases
dc.subject.mesh	Cardiovascular Diseases
dc.subject.mesh	HIV Infections
dc.subject.mesh	Humans
dc.subject.mesh	Medication Adherence
dc.subject.mesh	Noncommunicable Diseases
dc.title	Community Group-Based Models of Medication Delivery: Applicability to Cardiovascular Diseases.
dc.type	Journal Article
utslib.citation.volume	16
utslib.location.activity	England
utslib.for	1102 Cardiorespiratory Medicine and Haematology
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
utslib.copyright.status	open_access	*
dc.date.updated	2021-12-12T08:03:22Z
pubs.issue	1
pubs.publication-status	Published
pubs.volume	16
utslib.citation.issue	1

Abstract:

The rising global burden of chronic non-communicable diseases (NCDs) has put a strain on healthcare systems globally, especially in low- and middle-income countries, which have seen disproportionate mortality rates due to non-communicable diseases. These deaths are in part due to challenges with medication adherence, which are compounded by lack of access to medication and weak community support systems. This paper aims to propose a potential solution using models of service delivery in HIV/AIDS, given the many similarities between NCD and HIV/AIDS. Models that have been particularly effective in HIV/AIDS are the community-based peer-support medication delivery groups: medication adherence clubs and community antiretroviral therapy (ART) groups. The positive outcomes from these models, including improved medication adherence and patient satisfaction, provide evidence for their potential success when applied to non-communicable diseases, particularly hypertension and cardiovascular disease.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/152245